Literature DB >> 1612578

Diabetic mastopathy: a distinctive clinicopathologic entity.

J E Tomaszewski1, J S Brooks, D Hicks, V A Livolsi.   

Abstract

Insulin-dependent diabetics may manifest evidence of autoimmune diseases involving endocrine or other organs. Rare cases of a peculiar fibrous and inflammatory lesion of the breast in diabetic patients have been previously described; however, the pathologic and clinical features that uniquely characterize these cases have not been defined or distinguished from other chronic inflammatory and fibrosing conditions in the breast. We studied eight patients with breast masses and longstanding insulin-dependent diabetes and compared them with 36 nondiabetic or short-duration diabetic patients with fibrosis and chronic mastitis. The longstanding diabetic patients presented with clinical breast masses ranging in size from 2 to 6 cm. Six of the eight patients had documented diabetic nephropathy, retinopathy, or neuropathy. Pathologically, these lesions showed lymphocytic lobulitis and ductitis, lymphocytic vasculitis (predominantly B cell), and dense keloid-like fibrosis that in many cases (six of eight) contained peculiar epithelioid cells embedded in dense fibrous stroma. We have provisionally labeled these cells "epithelioid fibroblasts" (EFBs). Although the features of lymphocytic lobulitis, ductitis, and/or vasculitis may occasionally be encountered in nondiabetic breast biopsies, EFBs appear to be unique to the diabetic condition. Control cases of chronic mastitis in nondiabetic or short-duration diabetes patients failed to show the complete constellation of lymphocytic lobulitis and ductitis, vasculitis, keloidal fibrosis, and EFBs. Diabetic mastopathy may represent an immune reaction to abnormal matrix accumulation. A hypothesis is presented.

Entities:  

Mesh:

Year:  1992        PMID: 1612578     DOI: 10.1016/0046-8177(92)90348-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

1.  Deciduoid-like stromal cells in a diabetic patient with bilateral gynecomastia: a potential diagnostic pitfall.

Authors:  Gaetano Magro; Piero Gangemi; Loredana Villari; Paolo Greco
Journal:  Virchows Arch       Date:  2004-09-17       Impact factor: 4.064

2.  A metabolic syndrome case presenting with lymphocytic mastitis.

Authors:  Betul Ekiz Bilir; Neslihan Soysal Atile; Bulent Bilir; Sibel Guldiken; Nermin Tuncbilek; Fulya Oz Puyan; Atakan Sezer; Irfan Coskun
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

3.  HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast.

Authors:  A H Lee; A C Bateman; S J Turner; J M Theaker; W M Howell
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

Review 4.  Mastopathy and diabetes.

Authors:  Yogish C Kudva; Carol A Reynolds; Timothy O'Brien; Thomas B Crotty
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

5.  Diabetic mastopathy: a case report.

Authors:  A Giunta; R Vigneri; M Manusia; S Squatrito; L Tomaselli
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

6.  Sclerosing lymphocytic lobulitis in the male breast.

Authors:  A H Lee; B Zafrani; G Kafiri; S Rozan; R R Millis
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

7.  Diabetic mastopathy.

Authors:  Smita Sankaye; Sushil Kachewar
Journal:  Australas Med J       Date:  2012-06-30

8.  A diabetic breast lump.

Authors:  Sanjay A Pai; M G Bhat
Journal:  J R Soc Med       Date:  2005-02       Impact factor: 18.000

9.  Diabetic Mastopathy: A Case Report and Literature Review.

Authors:  G Neetu; R Pathmanathan; Ngun Kok Weng
Journal:  Case Rep Oncol       Date:  2010-07-16

10.  Identification of Microbiota Biomarkers With Orthologous Gene Annotation for Type 2 Diabetes.

Authors:  Yu-Hang Zhang; Wei Guo; Tao Zeng; ShiQi Zhang; Lei Chen; Margarita Gamarra; Romany F Mansour; José Escorcia-Gutierrez; Tao Huang; Yu-Dong Cai
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.